-
Mashup Score: 2
Patients experience a “general decline” in skeletal muscle mass after surgery for gastrointestinal cancer, but the extent depends on the type of tumor and treatment.
Source: cancernursingtoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 21
Summary:. Liquid biopsies are emerging as powerful minimally invasive approaches that have the potential to solve several long-standing problems spanning the continuum of cancer care: early detection of cancer, minimal residual disease tracking, and refinement of the heterogeneity of clinical responses together with therapeutic response monitoring in the metastatic setting. Existing challenges driven by technical limitations and establishment of the clinical value of liquid biopsies represent fields of active research that call for convergence science approaches to bridge scientific discovery with clinical care.
Source: aacrjournals.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 3CEBP Frederick P. Li Impact Award | Cancer Epidemiology, Biomarkers & Prevention | American Association for Cancer Research - 13 day(s) ago
CEBP Frederick P. Li Impact Award | Cancer Epidemiology, Biomarkers & Prevention | American Association for Cancer Research .aacrcontent {font-size: 16px; height: 100%;} .aacrcontent .banner{ width: 100% margin: -20px; } .aacrcontent .banner-sm{ display: none; } .boxes {float: left; margin: 0 12px 0 0; width: 218px;} .right{float: right; margin: 0 16px 16px 16px; padding: 16px; width: 220px; background-color: #f0f0f0; border: solid 1px #ddd;} #aacrcontent2 { box-shadow: 3px 3px 6px…
Source: aacrjournals.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 20
Summary:. Liquid biopsies are emerging as powerful minimally invasive approaches that have the potential to solve several long-standing problems spanning the continuum of cancer care: early detection of cancer, minimal residual disease tracking, and refinement of the heterogeneity of clinical responses together with therapeutic response monitoring in the metastatic setting. Existing challenges driven by technical limitations and establishment of the clinical value of liquid biopsies represent fields of active research that call for convergence science approaches to bridge scientific discovery with clinical care.
Source: aacrjournals.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0From AACR 2024 - 17 day(s) ago
Nature Reviews Clinical Oncology – From AACR 2024
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Claudio Cerchione, MD, PhD, Shares Promising Data on Emavusertib in AML | Blood Cancers Today - 19 day(s) ago
Claudio Cerchione, MD, PhD, describes his presentation from AACR 2024 on a emavusertib triplet in patients with AML.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 0PSMA-Directed Targeted Alpha Therapy Shows Activity in Heavily Pretreated Metastatic CRPC - 22 day(s) ago
FPI-2265 showed promising activity in patients with metastatic castration-resistant prostate cancer which was similar to prior safety and efficacy data reported.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
A microRNA assay combined with CA19-9 displayed diagnostic accuracy in the early detection of pancreatic cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 7
On this week’s Touching Base podcast, the GEN editors discuss the launch of Nvelop Therapeutics, a new start-up leveraging approaches developed by gene editing pioneers David Liu, PhD, and J. Keith Joung, MD, PhD, to advance delivery of genetic cargo. The GEN editors also recap highlights from the American Association for Cancer Research (AACR) annual meeting held in San Diego, California.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 10Study findings highlight potential of novel immunotherapy strategies - AACR Annual Meeting News - 23 day(s) ago
Sundar Jagannath, MD, and other presenters discussed emerging results on immunotherapy approaches beyond immune checkpoint inhibitors during a clinical trials plenary session.
Source: www.aacrmeetingnews.orgCategories: General Medicine News, Oncologists1Tweet
📰 News from #AACR24: Patients experience a “general decline” in skeletal muscle mass after surgery for GI cancer, but the extent depends on the type of tumor and treatment, according to a study presented by a team from @kumamotoUniv_PR. ➡️ Read more: https://t.co/gzUq22m7S3 https://t.co/6TMLxnmm5v